Mylan N.V. (NASDAQ:MYL) saw unusually large options trading activity on Wednesday. Stock investors purchased 16,282 call options on the company. This represents an increase of approximately 531% compared to the average daily volume of 2,581 call options.
A number of research analysts recently issued reports on MYL shares. UBS AG reiterated a “buy” rating and issued a $46.00 price target (down previously from $50.00) on shares of Mylan N.V. in a research note on Thursday, August 10th. Citigroup Inc. upgraded shares of Mylan N.V. from a “neutral” rating to a “buy” rating and upped their price target for the company from $36.00 to $42.00 in a research report on Wednesday, August 16th. Mizuho reissued a “buy” rating and issued a $37.00 price objective (down from $53.00) on shares of Mylan N.V. in a research note on Sunday, August 20th. BMO Capital Markets reaffirmed a “buy” rating and set a $45.00 price target on shares of Mylan N.V. in a research note on Friday, September 29th. Finally, ValuEngine raised shares of Mylan N.V. from a “hold” rating to a “buy” rating in a research note on Monday, October 2nd. One analyst has rated the stock with a sell rating, nine have issued a hold rating and twelve have issued a buy rating to the company’s stock. The company currently has an average rating of “Buy” and an average price target of $41.21.
Mylan N.V. (NASDAQ MYL) opened at 38.54 on Wednesday. The company’s 50-day moving average price is $33.26 and its 200 day moving average price is $36.26. Mylan N.V. has a 52 week low of $29.39 and a 52 week high of $45.87. The company has a market capitalization of $20.67 billion, a PE ratio of 31.16 and a beta of 1.30.
Mylan N.V. (NASDAQ:MYL) last issued its quarterly earnings results on Wednesday, August 9th. The company reported $1.10 EPS for the quarter, missing the consensus estimate of $1.18 by ($0.08). Mylan N.V. had a net margin of 5.51% and a return on equity of 22.42%. The company had revenue of $2.96 billion for the quarter, compared to analyst estimates of $3 billion. During the same period last year, the company posted $1.16 earnings per share. The business’s revenue for the quarter was up 15.7% on a year-over-year basis. On average, equities research analysts anticipate that Mylan N.V. will post $4.58 EPS for the current year.
Several institutional investors and hedge funds have recently added to or reduced their stakes in MYL. Global X Management Co. LLC lifted its holdings in Mylan N.V. by 91.6% during the 1st quarter. Global X Management Co. LLC now owns 3,015 shares of the company’s stock worth $118,000 after purchasing an additional 1,441 shares during the last quarter. TLP Group LLC acquired a new stake in Mylan N.V. during the 1st quarter worth approximately $200,000. Doliver Capital Advisors LP acquired a new stake in Mylan N.V. during the 2nd quarter worth approximately $201,000. Eagle Global Advisors LLC acquired a new stake in Mylan N.V. during the 2nd quarter worth approximately $205,000. Finally, Sheaff Brock Investment Advisors LLC bought a new position in Mylan N.V. during the 2nd quarter worth $210,000. 71.95% of the stock is owned by institutional investors.
TRADEMARK VIOLATION NOTICE: “Stock Traders Purchase Large Volume of Call Options on Mylan N.V. (NASDAQ:MYL)” was published by BBNS and is the property of of BBNS. If you are reading this piece on another domain, it was copied illegally and republished in violation of US and international trademark and copyright legislation. The legal version of this piece can be read at https://baseballnewssource.com/markets/investors-purchase-high-volume-of-mylan-n-v-call-options-myl/1700978.html.
Mylan N.V. Company Profile
Mylan N.V. is a global pharmaceutical company. The Company develops, licenses, manufactures, markets and distributes generic and branded generic products for resale by others; specialty pharmaceuticals, and active pharmaceutical ingredients (APIs). It operates through two segments: Generics and Specialty.
Receive News & Ratings for Mylan N.V. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mylan N.V. and related companies with our FREE daily email newsletter.